title: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification.
abstract: To better understand the molecular mechanisms that underlie the tumorigenesis and progression of clear cell renal cell carcinoma (ccRCC), we studied the gene expression profiles of 29 ccRCC tumors obtained from patients with diverse clinical outcomes by using 21,632 cDNA microarrays. We identified gene expression alterations that were both common to most of the ccRCC studied and unique to clinical subsets. There was a significant distinction in gene expression profile between patients with a relatively nonaggressive form of the disease [100% survival after 5 years with the majority (15/17 or 88%) having no clinical evidence of metastasis] versus patients with a relatively aggressive form of the disease (average survival time 25.4 months with a 0% 5-year survival rate). Approximately 40 genes most accurately make this distinction, some of which have previously been implicated in tumorigenesis and metastasis. To test the robustness and potential clinical usefulness of this molecular distinction, we simulated its use as a prognostic tool in the clinical setting. In 96% of the ccRCC cases tested, the prediction was compatible with the clinical outcome, exceeding the accuracy of prediction by staging. These results suggest that two molecularly distinct forms of ccRCC exist and that the integration of expression profile data with clinical parameters could serve to enhance the diagnosis and prognosis of ccRCC. Moreover, the identified genes provide insight into the molecular mechanisms of aggressive ccRCC and suggest intervention strategies.
authors.affiliation: Laboratories of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: D R
authors.initials: DR
authors.lastname: Rhodes
authors.forename: K A
authors.initials: KA
authors.lastname: Furge
authors.forename: H
authors.initials: H
authors.lastname: Kanayama
authors.forename: S
authors.initials: S
authors.lastname: Kagawa
authors.forename: B B
authors.initials: BB
authors.lastname: Haab
authors.forename: B T
authors.initials: BT
authors.lastname: Teh
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000235:genetics* / Q000401:mortality; D002292:Carcinoma, Renal Cell / Q000235:genetics* / Q000401:mortality; D005500:Follow-Up Studies; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007564:Japan / Q000453:epidemiology; D007680:Kidney Neoplasms / Q000235:genetics* / Q000401:mortality; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D012306:Risk; D016896:Treatment Outcome
chemical_list: D009363:Neoplasm Proteins